Keep up to date with what is happening in the world of anticoagulation and support ACE
Buy individual copies of InReview online
NEWS & EVENTS
Campaign to prevent AF-related strokes launched today (15th June 2016) Over half a million people in the UK with atrial fibrillation are either not being given anticoagulant therapy to reduce their risk of stroke or are taking aspirin. ACE has joined with patient charities and healthcare professionals to to try to reduce the number of unceccessary AF-related strokes.
Deep vein thrombosis is a serious condition that occurs when blood clots form inside a vein located deep in your leg. One possible way to help reduce the risk of blood clots is to increase the amount of blood flow through the calf veins. One device that can do that is the Geko device.
Download the article
AntiCoagulation Europe (ACE) are working in partnership with LEO Pharma and their research partners to find people who have cancer and have experienced thrombosis (usually referred to as a blood clot, Deep Vein Thrombosis (DVT) or a Pulmonary Embolism (PE) to join their ViP programme. The ViP programme is designed to bring patients with similar experiences together, so that they can share their stories and help to build activities and ideas which will improve the patient experience for many others. Please click on the title above to find out more.
NICE has issued technology appraisal guidance on the use of the 4 non-vitamin K antagonist oral anticoagulants (NOACs), apixaban, dabigatran, edoxaban and rivaroxaban, in several clinical settings. All 4 NOACs must be included in local formularies for use in line with this guidance, with no additional funding or formulary restrictions. nice.org.uk/guidance/ktt16
You can now buy individual copies of our magazine InReview online for £3.00. Just click on the flashing image above. If you want to support us on a long term basis you can still sign up to be a member on the join us page and receive 4 copies for £10.00. We hope you enjoy reading InReview
The National Institute for Health and Care Excellence (NICE) has recommended Edoxaban (Lixiana) as an option for the treatment and secondary prevention of deep vein thrombosis and pulmonary embolism and for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation
Welcome to Anticoagulation Europe
Patient Experience Videos
By the end of 2016, there will be more than 1,000 people diagnosed with cancer every day in the UK. One of the side effects of cancer and its treatment can be blood clots. Blood clots pose a very significant risk to cancer patients. Up to 20% of cancer patients will experience a blood clot.
Many patients are not made aware of there risk of developing a blood clot when they have cancer.
Teresa’s video shares her experience of having cancer and deep vein thrombosis.
Are you taking warfarin? Are you thinking about self-monitoring your INR? Roy’s video shares his experience of the benefits of self-monitoring
We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.
You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds, at no cost to you, click on Give as You Live at the bottom of the page.
AntiCoagulation Europe are raising free donations through easyfundraising.
If you’re shopping online then you could help, and it won’t cost you a penny!
Here’s how easy it is to do:
Just visit a retailer or Amazon via the easyfundraising website and any purchases you make will raise a free donation for us. It’s that simple!
They work with the leading retailers including Amazon, John Lewis, Argos and Marks and Spencer to name but a few.
It takes just a couple of minutes to register for free and no payment details are needed.
Please visit their page to find out more: